FDA Drug Application (021351) for OXYTROL by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number021351
Product Number002
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage3.9MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOXYTROL
Active IngredientOXYBUTYNIN



Back to FDA Applications sponsored by ALLERGAN SALES LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.